Moher D: Publication bias. Lancet. 1993, 342: 1116-
CAS
PubMed
Google Scholar
Egger M, Smith GD: Misleading meta-analysis. BMJ. 1995, 311: 753-754.
CAS
PubMed
PubMed Central
Google Scholar
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet. 1991, 337: 867-872. 10.1016/0140-6736(91)90201-Y.
CAS
PubMed
Google Scholar
Klassen TP, Wiebe N, Russell K, Stevens K, Hartling L, Craig WR, Moher D: Abstracts of randomized controlled trials presented at the society for pediatric research meeting: an example of publication bias. Arch Pediatr Adolesc Med. 2002, 156: 474-479.
PubMed
Google Scholar
Timmer A, Hilsden RJ, Cole J, Hailey D, Sutherland LR: Publication bias in gastroenterological research - a retrospective cohort study based on abstracts submitted to a scientific meeting. BMC Med Res Methodol. 2002, 2: 7-10.1186/1471-2288-2-7.
PubMed
PubMed Central
Google Scholar
Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW: Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA. 2006, 295: 281-1287. 10.1001/jama.295.11.1281.
Google Scholar
Blumle A, Antes G, Schumacher M, Just H, von Elm E: Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics. 2008, 34: e20-10.1136/jme.2008.024521.
CAS
PubMed
Google Scholar
von Elm E, Rollin A, Blumle A, Huwiler K, Witschi M, Egger M: Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee. Swiss Med Wkly. 2008, 138: 197-203.
PubMed
Google Scholar
Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B: Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003, 326: 1171-1173. 10.1136/bmj.326.7400.1171.
PubMed
PubMed Central
Google Scholar
Liebeskind DS, Kidwell CS, Sayre JW, Saver JL: Evidence of publication bias in reporting acute stroke clinical trials. Neurology. 2006, 67: 973-979. 10.1212/01.wnl.0000237331.16541.ac.
PubMed
Google Scholar
Thomas B, Mclnnes A: [O33] The Cochrane Stroke Group's Specialised Register of Trials: A Comprehensive and Unique Resource for Reviewers. Cochrane Colloquium Proceedings: 5-9. 1999, October ; Rome
Google Scholar
Sandercock P, Algra A, Anderson C, Bereczki D, Berge E, Bowen A: Cochrane Stroke Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2009, Art. No.: STROKE, 2
Google Scholar
Learning to identify and classify reports of controlled trials in healthcare journals. http://apps1.jhsph.edu/cochrane/srch.htm
True random number service. http://www.random.org
Gardner MJ, Altman DG: Calculating confidence intervals for proportions and their differences. Statistics with confidence: confidence intervals and statistical guidelines. Edited by: Gardner MJ, Altman DG. 1989, London: BMJ, 28-33. 1
Google Scholar
TUCSON: Safety study of microbubbles with transcranial ultrasound and tPA in the management of acute ischemic stroke. http://www.strokecenter.org/trials/
Alvarez-Sabin J, Chacon P, Molina CA, Arenillas JF, Ribo M, Fernandez-Cadenas I, Rosall A, Penalba A, Pujadas F, Montaner J: Triflusal is superior to aspirin suppressing the inflammatory response that follows ischemic attack [abstract]. Cerebrovasc Dis. 2004, 17: s109-
Google Scholar
ARTIST+. http://www.strokecenter.org/trials/
ARTIST MRI. http://www.strokecenter.org/trials/
Orgogozo JM, Massey D, Whitehead J, Lataste X: Prediction of functional recovery after middle cerebral artery infarction [abstract]. Cerebrovasc Dis. 1994, 4: 242-10.1016/S1052-3057(10)80099-0.
Google Scholar
Awadh MMM, Ali S, Sherif MA, Afify H, Aref H, Moustafa R, Abdulghani O: Large-dose loading clopidogrel is well tolerated in ischaemic stroke up to 24 hours from onset. Proceedings of the UK Stroke Forum Conference: 4-6. 2007, December ; Harrogate
Google Scholar
Schabitz WR, Laage R, Schwab S, Schneider D, Hamann G, Rosenkranz M: AX200 (G-CSF) for the treatment of acute ischemic stroke (AXIS) [abstract]. Stroke. 2008, 39: 561-
Google Scholar
Balkuv-Ulutin S, Hacihanefioglu M, Ulutin ON: Clinical and laboratory results obtained with defibrotide in the cases of acute stroke [abstract]. Thromb Haemost. 1989, 62: 585-
Google Scholar
Combined aspirin, clopidogrel and dipyridamole versus aspirin alone in acute stroke; a safety, tolerability and feasibility study. https://portal.nihr.ac.uk/Profiles/NRR.aspx?Publication_ID=N0170106720
Bergamasco B, Gentile S, Tarenzi L, Scarzella L: Cyticholine in acute ischemic stroke: results of a controlled multicentric double blind study [abstract]. Electroencephalogr Clin Neurophysiol. 1986, 64: 98P-
Google Scholar
Bo W, Ming L, Song T: A randomized controlled trial of ligustrazine for acute ischemic stroke [abstract]. J Neurol Sci. 2005, 238: s415-
Google Scholar
The SaTIS Investigators: Safety of tirofiban in acute ischemic stroke (SaTIS) [abstract]. Cerebrovasc Dis. 2006, 21: s60-10.1159/000090004.
Google Scholar
Caille JM, Bidabe AM, Dartigues JF, Pere JJ, Orgogozo JM: Action of an anti-aldosterone agent on ischemic cerebral oedema. A randomised therapeutic trial [abstract]. Neuroradiology. 1982, 22: 272-
Google Scholar
Chandra B: Neuroprotective drugs in the treatment of acute ischemic stroke. J Stroke Cerebrovasc Dis. 1997, 6: 453-10.1016/S1052-3057(97)80116-4.
Google Scholar
ROSIE-CT: ReoPro retavase reperfusion of stroke safety study - imaging evaluation with computed tomography. http://www.strokecenter.org/trials/
Chen W-H, Lien L-M, Fang S-C, Chiu H-C: Low molecular weight heparin for acute ischemic stroke. Annual Meeting of Taiwan Stroke Society: 22-23. 2003, March ; Taipei
Google Scholar
Clark WM, Coull BM: Randomised trial of CGS19755 a glutamate antagonist, in acute ischaemic stroke treatment [abstract]. Neurology. 1944, 44: A270-
Google Scholar
Fiblast Phase 3: European-Australian Fiblast (Trafermin) in acute stroke. http://www.strokecenter.org/trials/
Block GA, 1102-003 Study Group: Final results from a dose-escalating safety and tolerance study of the non-competitive NMDA antagonist CNS 1102 in patients with acute cerebral ischemia [abstract]. Stroke. 1995, 26: 185-
Google Scholar
Cuparnecu B: Efficacy of cerebrolysin in patients with ischaemic stroke of the middle cerebral artery [abstract]. Pharmacol Toxicol. 2001, 89: s136-
Google Scholar
Dan G-A, Gonta A, Serbanescu A, Ionete C: Improvement of outcome in patients with acute ischaemic stroke treated with fragmin. Proceedings of the 7th International Symposium on Thromboembolic Diseases: 9-10 June 2000; Palma de Mallorca. Haemostasis. Edited by: Haas S, Marder VJ, Samama M-M. 2000, 30: 168-169.
Google Scholar
Davalos EA, de Cendra E, Genis D, Teruel J, Ruibal A, Musoles S: Double blind controlled trial of nicardipine versus placebo in the treatment of the acute phase of cerebral infarction [abstract]. Neurologia. 1992, 7: 157-
Google Scholar
Defer G, Cesaro P, Moretti JL, Cinotti L, Degos JD: The cerebral effect of one-week intravenous administration of nicergoline in stroke patients: a SPECT study [abstract]. J Neurol. 1988, 235: s84-
Google Scholar
Delwaide PJ, de Pasqua V, Lehert P, D'Hooge R: Naftidrofuryl and quantified EEG of patients with ischemic stroke. A double-blind controlled trial [abstract]. J Stroke Cerebrovasc Dis. 1992, 2: s111-
Google Scholar
Dib H, Horozoglu H, Afsar N, Ekinci G, Aktan S: The effect of statins on infarct size and prognosis [abstract]. Cerebrovasc Dis. 2006, 21: s146-
Google Scholar
Mori E, Takakura K, Yamaguchi T, Terashi A, Saito I, Shinohara Y, Kikuchi H, Tanikawa T, Kobayashi S, Kobayashi N, Machida T: Multicenter trial of a novel modified t-PA, E6010 by iv bolus injection in patients with acute carotid artery territory stroke [abstract]. Cerebrovasc Dis. 1996, 6: 191-
Google Scholar
Zimmerman TR, Kidwell CS, Fisher M, Fiebach JB, Davalos A, Cheung Y-K, Arima K: Piclozotan (SUN N4057) in patients with acute ischemic stroke and MRI penumbra: a double-blind placebo-controlled multicenter study - the EPIC trial. Proceedings of the 15th European Stroke Conference: 16-19. 2006, May ; Brussels
Google Scholar
Fisher M: Eliprodil [abstract]. Cerebrovasc Dis. 1996, 6: 189-
Google Scholar
ROSIE: ReoPro retevase reperfusion of stroke safety study - imaging evaluation. http://www.strokecenter.org/trials/
Fayad P, Caplik J, Culligan N, Edwards K, Maisel J, Moonis M, Newman G, Srinivas N, Wirkowski E, Bozik M: Safety, tolerability, and pharmacokinetics of intravenous BMS-204352: a novel maxi-K channel opener, in patients up to 48 hours after acute ischemic stroke [abstract]. Cerebrovasc Dis. 2000, 10: s71-
Google Scholar
The FIBLAST Safety Study Group: Clinical safety trial of intravenous basic fibroblast growth factor (bFGF, FIBLAST) in acute stroke [abstract]. Stroke. 1998, 29: 287-
Google Scholar
Hommel M: Fraxiparine in ischaemic stroke study (FISS bis) [abstract]. Cerebrovasc Dis. 1998, 8: s19-10.1159/000047514.
Google Scholar
Fogari R, Pasotti C, Zoppi A, Corradi L, Mugellini A, Preti P, Derosa G, Rinaldi A: Effect of perindopril and atenolol on plasma PAI-1 in hypertensive patients with acute ischemic stroke [abstract]. Stroke. 2003, 34: 309-
Google Scholar
Galeas T, Contos T, Exarhos P, Galea V, Valotasiou B: The role of magnesium (Mg) a natural calcium (Ca) antagonist in the treatment of acute ischemic stroke (AIS) (clinical study) [abstract]. Cerebrovasc Dis. 1999, 9: s102-10.1159/000015906.
Google Scholar
Garcia Pastor A, Diaz OF, Gil Nunez AC, Villanueva Osorio JA: Tolerability and efficacy of the combination of piracetam and citicoline in acute ischemic stroke. A randomized comparative open study [abstract]. Stroke. 2004, 35: e286-
Google Scholar
Garcia Tigera J, Martinez DR: Levamisol, a new treatment for cerebral infarction [abstract]. J Neurol. 1994, 241: s162-
Google Scholar
Study of ONO-2506 in patients with acute ischemic stroke. http://www.clinicaltrials.gov/ct2/show/NCT00229177?term=ONO-2506%26rank=1
MITI-IV: Intravenous administration of microplasmin for treatment of acute ischemic stroke. http://www.strokecenter.org/trials/
Giroux C, Rosen P, Scatton B: Preclinical, pharmacology and clinical safety profile of eliprodil, an atypical NMDA receptor antagonist. Pharmacology of Cerebral Ischemia 1994. Edited by: Krieglstein J, Oberpichler-Schwenk H. 1994, Stuttgart: Wissenschaftliche Verglagsgesellschaft, 643-648.
Google Scholar
Guillen F, Buendia C, Herrera J: CDP-choline in the treatment of acute ischaemic stroke [abstract]. J Neurol. 1995, 242: s76-
Google Scholar
Gusev EI, Skvortsova VI, Komissarova IA: Glycine in therapy of acute ischemic stroke [abstract]. Eur J Neurol. 1997, 4: s78-
Google Scholar
Cerebrolysin in acute ischemic stroke. http://www.strokecenter.org/trials/
HALT: Hu23F2G phase 3 stroke trial. http://www.strokecenter.org/trials/
Hamamoto M, Nagao T, Kanda A, Ichiseki H, Miyazaki T, Terashi A: Hypervolemic hemodilution therapy for the elderly patients with atherothrombotic and hemodynamic ischemic stroke [abstract]. J Stroke Cerebrovasc Dis. 1992, 2: s136-10.1016/S1052-3057(10)80222-8.
Google Scholar
Oral aspirin vs intravenous heparin for acute ischemic stroke progression. http://www.strokecenter.org/trials/
Hernandez Fustes O, Macarini L, Munhoz R, Panfilio C, Moreira A, Arteaga C: Evaluation of the neuroprotection with citicolina in the treatment of the acute cerebral infarct [abstract]. J Neurol Sci. 2005, 238: s399-
Google Scholar
Huang P, Li XH, Qiao LJ: A study on the changes in plasma coagulative, anticoagulative, fibrinolytic activities in patients with cerebral infarction treated with low molecular weight heparin [abstract]. Hong Kong Med J. 2001, 7: 24-
CAS
Google Scholar
Iannuzzi NP, Liebeskind DS, Jacoby M, Arima K, Shimizu K, Zimmerman TR: Piclozotan (SUN N4057), a novel 5HT1A receptor antagonist, is well tolerated in patients with acute stroke [abstract]. Stroke. 2006, 37: 655-
Google Scholar
Jamieson DG, Reivich M, Alves W, Fazekas F, Kushner M, Chawluk J, Blackman D, Silver F, Alavi A: The effect of ganglioside (GM1) treatment in acute ischemic infarction: a positron emission tomography study [abstract]. J Cereb Blood Flow Metab. 1989, 9: s602-
Google Scholar
Ji S, Liu Y, Li T, Ma M: Effect observation of shuxuetong on nervous function defect of cerebral infarction. Chin J Clin Rehabil. 2003, 7: 866-867.
Google Scholar
Khrapova E, Chukhrova V, Kistenev B: Antioxidant emoxypine in complex treatment of patients with acute ischemic stroke [abstract]. Eur J Neurol. 1998, 5: s40-
Google Scholar
Kistenev B, Suslina Z, Maksimov M, Geraskina L: Clinical effects of antioxidant therapy in patients with acute cerebral infarction. III South American Conference on Cerebrovascular Diseases: 15-18. 1994, June ; Buenos Aires
Google Scholar
Konta Y, Aizu K, Fuziwara K, Matsui T: Evaluation of intravenous urokinase, ozagrel sodium and low molecular dextran therapy in acute ischemic stroke - comparison of infusion methods of urokinase [abstract]. Cerebrovasc Dis. 1996, 6: 187-
Google Scholar
Kopa J, Radai F: A new combination of neuroprotective drugs in the therapy of acute ischemic stroke (comparative study) [abstract]. Stroke. 2000, 31: 2840-
Google Scholar
Staszewski J, Kotowicz J, Swistak J, Stepien A: Intravenous insulin therapy in maintenance of euglycemia in nondiabetic acute stroke patients [abstract]. Cerebrovasc Dis. 2005, 19: s66-
Google Scholar
Kovacevic MS, Mrsulja BB, Bumbasirevic LJ, Jovanovic D, Zidverc J, Bugarski C, Dodic A, Pecic O: Acute nonhemorrhagic stroke: neurological and biochemical study [abstract]. J Stroke Cerebrovasc Dis. 1992, 2: s90-
Google Scholar
Kwiecinski H, Pniewski J, Kaminska A, Szyluk B: A randomized trial of fraxiparine in acute ischemic stroke [abstract]. Cerebrovasc Dis. 1995, 5: 234-
Google Scholar
Lee JH, Seo DC, Kim JS, Lee MC: Therapeutic efficacy of urokinase and heparin in acute ischaemic stroke [abstract]. Stroke. 1994, 25: 268-
Google Scholar
Li CY: Influence of ligustrazine in acute cerebral thrombosis [abstract]. Chinese Journal of Neurology & Psychiatry. 1986, 19: 386-
Google Scholar
Li BXY, Lang S, Zhang Z, Dong Q, Zhu K, Zhang Z: Defibrase for the treatment of acute ischemic stroke [abstract]. Circulation. 1999, 100: sI-36.
Google Scholar
Li C, Wang L, Dong W, Hu C: Fractal dimension of heart rate variability: a useful marker to predict the sudden unexpected death in patients with stroke. Proceedings of the 4th International Conference on Research Advances in Cerebrovascular Disease: 13-15. 2003, October ; Chengdu
Google Scholar
Dong Q, Lu C-Z, Zhen H-M: Low-molecular-weight heparin for the treatment of acute ischemic stroke: a randomized controlled trial [abstract]. Neurology. 2003, 60: A228-
Google Scholar
Lu XR, Mi ZZ, Yuan XD: Study of correlation between times of a disease and plasma fibrinogen molecular reactivity in patients with acute cerebral infarction [abstract]. Hong Kong Med J. 2001, 7: s42-
Google Scholar
Luo ZM, Yang L: A randomized controlled clinical trial of MgSO4 plus cyclophophamide and colchicine in patients suffered from acute cerebral infarction [abstract]. Hong Kong Med J. 2001, 7: 23-
Google Scholar
Luo Z, Zeng X, Chen H, Liu L, He L, Yuan G: Anti-inflammatory cell therapy for cerebral ischemic stroke in rats and patients. Proceedings of the 4th International Conference on Research Advances in Cerebrovascular Disease: 13-15. 2003, October ; Chengdu
Google Scholar
Maksimova M, Kistenev B, Khrapova E, Geraskina L, Smirnova I: Comparative analysis of the clinical efficiency of ischaemic stroke therapy [abstract]. Int Angiol. 1995, 14: s181-
Google Scholar
Mazagri R, Shuaib A, McPherson M, Deighton M: Amphetamine failed to improve motor function in acute stroke [abstract]. Can J Neurol Sci. 1995, 22: s25-
Google Scholar
McCormick M, McLean JR, Condon B, Hadley D, Muir KW: Randomized controlled trial of insulin in hyperglycemia: lesion volume progression depends on vessel recanalization [abstract]. Stroke. 2007, 38: 505-
Google Scholar
Metoki N, Konta Y, Baba Y, Okuguchi T, Matsui T, Fukuda M, Satoh K, Okumura K: Efficacy of combined therapy with ozagrel sodium and edaravone in patients with acute cerebral thrombosis [abstract]. Stroke. 2004, 35: e214-
Google Scholar
Mihout B, Malberin M, Salzman V, Guez D, Bogousslavsky J: Effect of almitrine-raubasine combination on functional recovery in patients with ischemic stroke [abstract]. J Neurol. 1994, 241: s78-
Google Scholar
Monaco P, Pastore L, Cottone A, Conti S: Effect of treatment with monosialotetraesosil-ganglioside (GM1) on neurological impairment in the acute and post-acute phases of the ischemic stroke [abstract]. J Stroke Cerebrovasc Dis. 1992, 2: s119-10.1016/S1052-3057(10)80333-7.
Google Scholar
Moriwaki H, Nagatsuka K, Miyashita K, Yamagami H, Yamawaki T, Naritomi H: Antipyretic therapy prevents the development of cerebral edema in acute embolic stroke: a pilot study using serial CT examinations [abstract]. Stroke. 2000, 31: 313-
Google Scholar
Crepin-Leblond T, Moulin T, Ziegler F, Bataillard M, Chopard JL, Chavot D, Rumbach L, Bonneville JF, Bogousslavsky J: A randomised trial of heparin therapy in acute ischemic stroke: first results [abstract]. Cerebrovasc Dis. 1994, 4: 259-
Google Scholar
Teal P, Lyden P, Kaste M, Davis S, Hacke W, Fierus M: Effects of repinotan in patients with acute ischemic stroke: phase IIb modified randomized exposure controlled trial (MRECT) [abstract]. Cerebrovasc Dis. 2005, 19: s68-
Google Scholar
Nakamura T, Uchiyama S, Tsutsumi Y, Shimizu Y, Iwata M: Renin-angiotensin system blockade safely reduces blood pressure without affecting cerebral blood flow in patients with acute ischemic stroke [abstract]. Stroke. 2007, 38: 517-10.1161/STROKEAHA.107.486522.
Google Scholar
PASS II: Piracetam in acute stroke study II. http://www.strokecenter.org/trials/
Effect of MK-0724 on the improvement of neurological damage and recovery from ischemic stroke. http://www.strokecenter.org/trials/
GRASP: glucose regulation in acute stroke patients. http://www.strokecenter.org/trials/
Peng XS: Antioxidant treatment in high-altitude ischaemic stroke [abstract]. Chinese Journal of Neurology & Psychiatry. 1994, 27: 303-
Google Scholar
Saltarelli MD, Weaver JJ, Hsu C, Bednar MM: Randomized double-blind, placebo-controlled study to evaluate the safety and efficacy of CP101,606 (Traxoprodil), an NR2B-selective N-methyl D-aspartate receptor antagonist, in subjects with acute ischemic stroke [abstract]. Stroke. 2004, 35: 241-
Google Scholar
Piradov MA, Suslina ZA, Lebedeva NV, Altunina MN, Shchukin JD: Piracetam in acute ischemic stroke [abstract]. Cerebrovasc Dis. 1992, 2: 235-
Google Scholar
Pokrupa R, Hakim A, Villanueva J, Francis G, Wolfe L: Clinical study of prostacyclin infusion after acute ischemic stroke [abstract]. Can J Neurol Sci. 1986, 13: 165-
Google Scholar
Steiner TJ: Naftidrofuryl in the treatment of acute cerebral hemisphere infarction (ACHI). Stroke. 1996, 27: 195-
Google Scholar
Fosphenytoin Phase 3: Multicenter study to evaluate the safety of intravenous fosphenytoin in patients with acute ischemic stroke. http://www.strokecenter.org/trials/
Qiang D: The dynamic study of stroke MRI in hyperacute stroke patients with thrombolysis [abstract]. Hong Kong Med J. 2001, 7: 16-
Google Scholar
Haley EC: High-dose tirilazad for acute stroke (RANTTAS II) [letter]. Stroke. 1998, 29: 1256-1257.
PubMed
Google Scholar
RECT: Repinotan - randomized exposure controlled trial. http://www.strokecenter.org/trials/
Ricci S, Ricciotti E, Celani MG, Righetti E, Stragliotto E, Stracci F, Patrignani P: Differential suppression of thromboxane biosynthesis by indobufen and ASA in patients with ischaemic stroke [abstract]. Cerebrovasc Dis. 2003, 16: s114-10.1159/000070590.
Google Scholar
Rosenberg G, Angel I, Kozak A, Schneider D: Evaluation of safety and changes in the NIH Stroke Scale, Rankin, and Barthel scores following DP-b99 administration to acute stroke patients [abstract]. Stroke. 2004, 35: 338-10.1161/01.STR.0000135294.08862.5d.
Google Scholar
Teal PA, Sherman DG, Selchen DH, Grotta JC, Albers GW, Due BR: Arundic acid (ONO-2506 MK-0724) in acute ischemic stroke: results of RREACT study [abstract]. Stroke. 2007, 38: 472-
Google Scholar
The rt-PA/acute Stroke Study Group: An open safety/efficacy trial of rt-PA in acute thromboembolic stroke: final report [abstract]. Stroke. 1991, 22: 153-
Google Scholar
Rubiera M, Ribo M, Santamarina E, Delgado-Mederos R, Delgado P, Alvarez-Sabin J, Molina CA: Effects of blood pressure on the efficacy of microbubbles-enhanced sonothrombolysis in acute stroke [abstract]. Stroke. 2007, 38: 507-
Google Scholar
Sansone A, Gulotta G, Sparacia B, Alongi A, Savoia G, Sparacia GV: Effect of hyperbaric oxygen therapy on neurologic recovery after focal cerebral ischaemia [abstract]. Br J Anaesth. 1997, 78: s73-74.
Google Scholar
Overell J, Nazir F, Hilditch T, Lowe G, Lees KR: Vascular effects of statins in acute cerebral ischemia: the statins in acute stroke (SAS) trial [abstract]. Stroke. 2003, 34: 308-
Google Scholar
Shamalov NA, Stakhovskaya LV, Gubsky LV, Tikhonova IV, Smichkov AS, Skvortsova VI: Effects of the neuroprotective drug cerebrolysin on the infarct volume after acute ischemic stroke [abstract]. Cerebrovasc Dis. 2005, 19: s107-
Google Scholar
SIS: Sipatrigine in stroke. http://www.strokecenter.org/trials/
Staedt U, Heene DL, Bayerl JR, Schwarz M, Schwarz M: Comparative study with HAS and dextran of patients with cerebral ischemia. Neurological findings and a daily profile of rheological and hemostatic parameters [abstract]. Klin Wochenschr. 1985, 63: s18-
Google Scholar
Szczepanska-Szerej A, Wojczal , Stelmasiak Z: Anti-aggregating effect of indobufen (IB) in acute ischemic stroke [abstract]. Eur J Neurol. 1998, 5: s109-10.1046/j.1468-1331.1998.510109.x.
Google Scholar
Szczepanska-Szerej A, Kurzepa J, Wojczal J, Stelmasiak Z, Stryjecka-Zimmer M: Simvastatin prevents increasing MMP-9 activity in acute phase of ischemic stroke. J Neurol Sci. 2005, 238: s445-
Google Scholar
Tamura A, Amano T, Sherman DG, Houkin K, Asano T, Fukuuchi Y: Arundic acid (ONO-2506 MK-0724) for the treatment of acute ischemic stroke: phase II clinical trial in Japan [abstract]. Stroke. 2007, 38: s511-512.
Google Scholar
TEST: Tolerability of enecadin (INN) in acute ischemic stroke trial. http://www.strokecenter.org/trials/
Tietjen GE, Dombi T, Pulsinelli WA, Beckse T, Kulger AR, Mann ME: A double-blind, safety, and tolerance study of single intravenous doses of fosphenytoin in patients with acute ischemic stroke [abstract]. Neurology. 1996, 46: s424-
Google Scholar
Azzimondi G, Casmiro M, D'Alessandro R, Fiorani L, Nonino F: Italian trial on glycerol in ischemic stroke (trial Italiano sul glicerolo nell'ictus: TIGI) [abstract]. Stroke. 1994, 25: 2113-
Google Scholar
Molina CA, Ribo M, Rubiera M, Santamarina E, Delgado-Mederos R, Maisterra O: TNK induces faster MCA recanalization and leads to better short- and long-term clinical outcomes than native tPA. The TNK-TPA reperfusion stroke study [abstract]. Stroke. 2008, 39: 563-
Google Scholar
Toso V, D'Agnolo B, Feruglio FS, Basaglia N, Donati G, Falezza G, Bruno R, Salvato G: GM1 therapy of acute stroke. A multicentre trial [abstract]. Cerebrovasc Dis. 1992, 2: 210-
Google Scholar
Treib J, Behnke S, Seltmann A, Fischer C, Windisch F, Grauer MT, Schenk JF, Wenzel E, Haass A: Effects of a high-dose hypervolemic volume therapy using HES 200/0.5 or HES 70/0.5 on hemodynamics, hemorheology and coagulation in patients suffering from acute stroke. Results of a randomised double-blind study [abstract]. Cerebrovasc Dis. 1999, 9: s101-
Google Scholar
Edaravone and argatroban stroke therapy for acute ischemic stroke. http://www.strokecenter.org/trials/
Wardlaw JM, Lindley RI, Warlow CP, Sandercock PAG: A pilot study of intra-arterial thrombolysis for acute ischaemic stroke [abstract]. JNNP. 1994, 57: 251-
Google Scholar
Wester PO, Asplund K, Eriksson S, Hagg E, Lithner F, Strand T: Infusion of magnesium in patients with acute brain infarction [abstract]. Acta Neurol Scand. 1984, 70: 143-
Google Scholar
Sprigg N, Willmot MR, Gray LJ, Walker MF, Sunderland A, Bath PM: The effect of dexamphetamine on motor recovery and systemic and cerebral hemodynamics in subacute ichemic stroke [abstract]. Stroke. 2007, 38: 520-10.1161/STROKEAHA.107.482877.
Google Scholar
Wojczal J, Szczepanska-Szerej A, Stelmasiak Z: Pentoxifylline (PTX) and indobufen (IB) reduce platelet activation in the acute phase of ischemic stroke (IS) [abstract]. Eur J Neurol. 1998, 5: s108-
Google Scholar
Standardized evaluation of Chinese medicine injection for cerebral infarction. http://dlib.edu.cnki.net/kns50/Navigator.aspx?ID=9
Zeng X, Li Y: Effects of pravastatin on the function of dendritic cells and high sensitive C-reactive protein and clinical effects in patients with acute ischemic stroke [abstract]. Stroke. 2005, 36: 495-
Google Scholar
Zhang JJ, Deng M, Zhang Y, Sui W, Wang L, Sun A: A short-term assessment of recombinant human granulocyte colony-stimulating factor (RHG-CSF) in treatment of acute cerebral infarction [abstract]. Cerebrovasc Dis. 2006, 21: s143-144.
Google Scholar
Edwards K, CNS 1102-008 Study Group: Cerestat (aptiganel hydrochloride) in the treatment of acute ischemic stroke: results of a phase II trial [abstract]. Neurology. 1996, 46: s424-
Google Scholar
Anonymous: Eliprodil stroke trial halted. SCRIP. 1996, 2102: 20-
Google Scholar
Peinemann F, McGauran N, Sauerland S, Lange S: Negative pressure wound therapy: potential publication bias caused by lack of access to unpublished study results data. BMC Med Res Methodol. 2008, 8: 4-10.1186/1471-2288-8-4.
PubMed
PubMed Central
Google Scholar
Fletcher RW, Fletcher SW: Clinical epidemiology: the essentials. 2005, Baltimore: Lippincott Williams and Wilkins
Google Scholar
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0. http://www.cochrane-handbook.org
Roberts I: An amnesty for unpublished trials. One year on, many trials are unregistered and the amnesty remains open. BMJ. 1998, 317: 763-764.
CAS
PubMed
PubMed Central
Google Scholar
Hetherington J, Dickersin K, Chalmers I, Meinert CL: Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics. 1989, 84: 374-380.
CAS
PubMed
Google Scholar
Pearn J: Publication: an ethical imperative. BMJ. 1995, 310: 1313-1315.
CAS
PubMed
PubMed Central
Google Scholar
Chalmers I: Underreporting research is scientific misconduct. JAMA. 1990, 263: 1405-1408. 10.1001/jama.263.10.1405.
CAS
PubMed
Google Scholar
Tumber MB, Dickersin K: Publication of clinical trials: accountability and accessibility. J Intern Med. 2004, 256: 271-283. 10.1111/j.1365-2796.2004.01392.x.
CAS
PubMed
Google Scholar
Standard operating procedures for research ethics committees. http://www.nres.npsa.nhs.uk/news-and-publications/publications/standard-operating-procedures/
Shields PG: Publication bias is a scientific problem with adverse ethical outcomes: the case for a section for null results. Cancer Epidemiol Biomarkers Prev. 2000, 9: 771-772.
CAS
PubMed
Google Scholar
Random samples. Science. 2002, 296: 2137-
Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schultz KF, the CONSORT Group: CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008, 5: e20-10.1371/journal.pmed.0050020.
PubMed
PubMed Central
Google Scholar
Hopewell S, Altman DG, Moher D, Schultz KF: Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors.'. Trials. 2008, 9: 20-10.1186/1745-6215-9-20.
PubMed
PubMed Central
Google Scholar
Chalmers I: In the dark. New Scientist. 2004, 6: 9-
Google Scholar
Project to improve public reporting of clinical trials underway. http://www.nres.npsa.nhs.uk/news-and-publications/news/project-to-improve-public-reporting-of-clinical-trials-underway/
PRS Information: U.S. Public Law 110-85. http://prsinfo.clinicaltrials.gov/fdaaa.html